Cinnamic Acid

Cinnamic Acid

SCHEMBL122247

O=C(O)C=Cc1ccccc1.[CaH2]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCAR2 Q8TDS4 2/20 0.95
▸ HDAC3 O15379 2/20 0.95
▸ HDAC4 P56524 2/20 0.95
▸ HDAC1 Q13547 2/20 0.95
▸ HDAC2 Q92769 2/20 0.95
▸ HDAC8 Q9BY41 2/20 0.95
▸ HDAC6 Q9UBN7 2/20 0.95
▸ TNKS O95271 1/20 0.95
▸ HDAC7 Q8WUI4 1/20 0.95
▸ HDAC10 Q969S8 1/20 0.95
▸ HDAC11 Q96DB2 1/20 0.95
▸ TNKS2 Q9H2K2 1/20 0.95
▸ HDAC9 Q9UKV0 1/20 0.95
▸ HDAC5 Q9UQL6 1/20 0.95
▸ PLIN1 O60240 2/20 0.70
▸ LMNA P02545 2/20 0.70
▸ MAPT P10636 2/20 0.70
▸ RECQL P46063 2/20 0.70
▸ PLIN5 Q00G26 2/20 0.70
▸ ABHD5 Q8WTS1 2/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cinnamic Acid SCHEMBL122246 1.00 HCAR2 (0.95) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL29989544 0.97 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL3406486 0.97 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL1333 0.97 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL50466 0.97 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL653827 0.97 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL1332 0.97 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL1706935 0.97 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL653828 0.97 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL1721341 0.95 HCAR2 (0.95) HCAR2HDAC3HDAC4HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11850294-B2 Buffered microencapsulated compositions and methods PREMIER DENTAL PRODUCTS COMPANY (US) 2023-12-26 — — US claimed
US-20230118672-A1 SUBSTITUTED POLY(ALKYLENE OXIDE) AND SURFACTANT COMPOSITION SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2023-04-20 — — US claimed
CN-115583913-B Zinc burning inhibitor and preparation method and application thereof 广东工业大学 2023-03-17 — — CN claimed
CN-115583913-A Zinc burning inhibitor and preparation method and application thereof 广东工业大学 2023-01-10 — — CN claimed
CN-115304838-A Flame-retardant rubber plate containing microwave activated rubber powder and preparation method thereof 宣城新润发高分子科技有限公司 2022-11-08 — — CN claimed
CN-114931054-A Method for cultivating Chinese wampee fruit saplings with high survival rate 中国热带农业科学院三亚研究院 2022-08-23 — — CN claimed
US-20220193497-A1 METALLIC MONOMER USED AS IONOMERIC ADDITIVES FOR IONOMERS AND POLYOLEFINS TAYLOR MADE GOLF COMPANY, INC. (US) 2022-06-23 — — US claimed
US-20220079849-A1 BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS FIDELITY DIRECT LENDING LLC, AS ADMINISTRATIVE AGENT 2022-03-17 — — US claimed
EP-3642260-A1 SUBSTITUTED POLY(ALKYLENE OXIDE) AND SURFACTANT COMPOSITION SABIC Global Technologies B.V. (NL) 2020-04-29 — — EP claimed
US-20200078642-A1 METALLIC MONOMER USED AS IONOMERIC ADDITIVES FOR IONOMERS AND POLYOLEFINS TAYLOR MADE GOLF COMPANY, INC. 2020-03-12 — — US claimed
WO-2018234992-A1 SUBSTITUTED POLY(ALKYLENE OXIDE) AND SURFACTANT COMPOSITION SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-12-27 — — WO claimed
EP-1868940-B1 OBTAINING AMMONIUM DINITRAMIDE (ADN) CRYSTALS HERAKLES (FR) 2017-09-20 — — EP claimed
US-20160354645-A1 METALLIC MONOMER USED AS IONOMERIC ADDITIVES FOR IONOMERS AND POLYOLEFINS TAYLOR MADE GOLF COMPANY, INC. (US) 2016-12-08 — — US claimed
US-9012579-B2 Ionomer compositions and methods of making and using same FINA TECHNOLOGY, INC. (US) 2015-04-21 — — US claimed
US-20140005290-A1 Ionomer Compositions and Methods of Making and Using Same FINA TECHNOLOGY, INC. (US) 2014-01-02 — — US claimed
EP-2406308-A1 IONOMER COMPOSITIONS AND METHODS OF MAKING AND USING SAME Fina Technology, Inc. (US) 2012-01-18 — — EP claimed
US-20100234533-A1 Ionomer Compositions and Methods of Making and Using Same FINA TECHNOLOGY, INC. (US) 2010-09-16 — — US claimed
WO-2010105032-A1 IONOMER COMPOSITIONS AND METHODS OF MAKING AND USING SAME FINA TECHNOLOGY, INC. (US) 2010-09-16 — — WO claimed
US-7789980-B2 Preparation of ammonium dinitroamide (ADN) crystals, ADN crystals and energetic composites containing them SNPE MATERIAUX ENERGETIQUES (FR) 2010-09-07 — — US claimed
US-20090090441-A1 Preparation of Ammonium Dinitroamide (ADN) Crystals, ADN Crystals and Energetic Composites Containing Them SNPE MATERIAUX ENERGETIQUES (FR) 2009-04-09 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230118672-A1 SUBSTITUTED POLY(ALKYLENE OXIDE) AND SURFACTANT COMPOSITION DECR2, DECR1, C9 HCAR2 1725/4885HDAC3 2082/4885HDAC4 3874/4885
US-11850294-B2 Buffered microencapsulated compositions and methods CHMP4B, LIPA, APOB HCAR2 2917/4885HDAC3 1984/4885HDAC4 1883/4885
US-20220079849-A1 BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS CHMP4B, LIPA, APOB HCAR2 2917/4885HDAC3 1984/4885HDAC4 1883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback